FinkLynnKarenMDPhD

Clinical Trials

• Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma Start of enrollment: 1994 Jul 01

  Completed

  Phase 3

• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01

  Active, not recruiting

  Phase 3

• Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01

  Completed

  Phase 3

• A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01

  Completed

  Phase 2

• Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme Start of enrollment: 2014 May 01

  Completed

  Phase 1, Phase 2

• DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors Start of enrollment: 2014 Sep 11

  Completed

  Phase 1

• Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma Start of enrollment: 2024 Dec 01

  Suspended

  Phase 3

• A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification Start of enrollment: 2015 Jan 04

  Completed

  Phase 3

• Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Start of enrollment: 2016 Jul 01

  Active, not recruiting

  Phase 3

• A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy Start of enrollment: 2017 Dec 08

  Completed

  Phase 3

• Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects Start of enrollment: 2018 Jan 16

  Terminated

  Phase 3

• Join now to see all